Full Text
PDB1 COST-EFFECTIVENESS OF SWITCHING PATIENTS TO COMBINED GLIBENCLAMIDE AND METFORMIN (GLUCOVANCE) WHEN POORLY CONTROLLED WITH METFORMIN MONOTHERAPY-THE FRENCH PERSPECTIVE

Abstract

Authors

S Roze AJ Palmer L Cabrires S Comte

Back to Volume 5, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×